BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 17154160)

  • 1. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy.
    Peterson DE; Jones JB; Petit RG
    Cancer; 2007 Jan; 109(2):322-31. PubMed ID: 17154160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
    Rosen LS; Abdi E; Davis ID; Gutheil J; Schnell FM; Zalcberg J; Cesano A; Gayko U; Chen MG; Clarke S
    J Clin Oncol; 2006 Nov; 24(33):5194-200. PubMed ID: 17075109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies.
    Sorensen JB; Skovsgaard T; Bork E; Damstrup L; Ingeberg S
    Cancer; 2008 Apr; 112(7):1600-6. PubMed ID: 18300265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
    Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-level infrared laser therapy in chemotherapy-induced oral mucositis: a randomized placebo-controlled trial in children.
    Kuhn A; Porto FA; Miraglia P; Brunetto AL
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):33-7. PubMed ID: 19125084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.
    Peterson DE; Barker NP; Akhmadullina LI; Rodionova I; Sherman NZ; Davidenko IS; Rakovskaya GN; Gotovkin EA; Shinkarev SA; Kopp MV; Kulikov EP; Moiseyenko VM; Gertner JM; Firsov I; Tuleneva T; Yarosh A; Woon CW
    J Clin Oncol; 2009 Sep; 27(26):4333-8. PubMed ID: 19636011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.
    Choi K; Lee SS; Oh SJ; Lim SY; Lim SY; Jeon WK; Oh TY; Kim JW
    Clin Nutr; 2007 Feb; 26(1):57-62. PubMed ID: 16949180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High incidence-rate of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy (FEC100)].
    Fukazawa M; Kawaguchi H; Shigematsu H; Koga C; Mori E; Nishimura S; Nakamura Y; Satou S; Sawamura K; Kashiwaba K; Ohno S
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):395-8. PubMed ID: 22421766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial.
    Karthaus M; Rosenthal C; Huebner G; Paul H; Elser C; Hertenstein B; Krauter J; Scharmann T; Geissler RG; Heil G; Ganser A
    Bone Marrow Transplant; 1998 Oct; 22(8):781-5. PubMed ID: 9827976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer.
    Cerchietti LC; Navigante AH; Lutteral MA; Castro MA; Kirchuk R; Bonomi M; Cabalar ME; Roth B; Negretti G; Sheinker B; Uchima P
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1330-7. PubMed ID: 16765532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
    Wu HG; Song SY; Kim YS; Oh YT; Lee CG; Keum KC; Ahn YC; Lee SW
    Cancer; 2009 Aug; 115(16):3699-708. PubMed ID: 19514089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
    Semiglazov VF; Stepula VV; Dudov A; Schnitker J; Mengs U
    Anticancer Res; 2006; 26(2B):1519-29. PubMed ID: 16619567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial.
    Nottage M; McLachlan SA; Brittain MA; Oza A; Hedley D; Feld R; Siu LL; Pond G; Moore MJ
    Support Care Cancer; 2003 Jan; 11(1):41-7. PubMed ID: 12527953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
    Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
    Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study.
    Aquino VM; Harvey AR; Garvin JH; Godder KT; Nieder ML; Adams RH; Jackson GB; Sandler ES
    Bone Marrow Transplant; 2005 Oct; 36(7):611-6. PubMed ID: 16086046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a Plantago ovata-based herbal compound in prevention and treatment of oral mucositis in patients with breast cancer receiving chemotherapy: A double-blind, randomized, controlled crossover trial.
    Hasheminasab FS; Hashemi SM; Dehghan A; Sharififar F; Setayesh M; Sasanpour P; Tasbandi M; Raeiszadeh M
    J Integr Med; 2020 May; 18(3):214-221. PubMed ID: 32268991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial.
    Hunter A; Mahendra P; Wilson K; Fields P; Cook G; Peniket A; Crawley C; Hickling R; Marcus R
    Bone Marrow Transplant; 2009 Apr; 43(7):563-9. PubMed ID: 18997832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.